Abstract
Candida krusei infections are serious complications in neutropenic patients with hematological malignancies. We report the successful treatment of C. krusei infection with caspofungin in 3 allogeneic hematopoietic stem cell transplant recipients and 1 patient with induction chemotherapy for acute myeloid leukemia.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antifungal Agents / therapeutic use*
-
Candida / classification
-
Candida / drug effects*
-
Candidiasis / drug therapy*
-
Candidiasis / microbiology
-
Caspofungin
-
Echinocandins / therapeutic use*
-
Female
-
Hematologic Neoplasms / complications*
-
Hematopoietic Stem Cell Transplantation / adverse effects
-
Humans
-
Lipopeptides
-
Middle Aged
-
Neutropenia / complications
-
Transplantation, Homologous / adverse effects
-
Treatment Outcome
Substances
-
Antifungal Agents
-
Echinocandins
-
Lipopeptides
-
Caspofungin